The UAE diagnostic ultrasound market is projected to expand from USD 10.1 billion in 2025 to USD 20.3 billion by 2034, registering a CAGR of 7.3%. Growth is driven by the country’s smart hospital initiatives, rising preventive screening programs, and increasing adoption of portable and AI-enabled ultrasound systems. Favorable government policies under UAE Vision 2031, the expansion of specialty care centers, and the integration of AI diagnostic imaging into primary healthcare are boosting market penetration. With cardiology, obstetrics, oncology, and musculoskeletal imaging emerging as key applications, ultrasound systems are evolving from routine tools to core diagnostic assets across the UAE’s rapidly digitalizing healthcare ecosystem.

The UAE diagnostic ultrasound market will double from USD 10.1 billion in 2025 to USD 20.3 billion by 2034, driven by population health screening, chronic disease monitoring, and digital healthcare expansion. The hospital segment contributes 58% of total demand, while diagnostic imaging centers account for 27%. The portable ultrasound segment, expanding at 11% CAGR, is gaining traction due to telemedicine integration and remote rural deployments. The cardiology and obstetrics sectors lead usage, representing 45% of overall scans. Government initiatives, including Emirates Health Services’ digital imaging roadmap, are accelerating the adoption of smart diagnostic ecosystems.
The UAE’s healthcare transformation agenda is central to the market’s expansion. With a per capita healthcare spend of USD 1,600, the UAE ranks among the top in MENA. The transition to AI-enabled imaging is redefining clinical efficiency, cutting diagnostic times by up to 35%. The introduction of handheld ultrasound systems for home and remote diagnostics is widening accessibility. Hospitals like Cleveland Clinic Abu Dhabi and Mediclinic are early adopters of AI-assisted ultrasound analysis. Additionally, PPP-led smart hospital projects under Vision 2031 are generating demand for advanced equipment, while radiology integration platforms are facilitating centralized, cloud-based image sharing across emirates.

By product, cart-based ultrasound systems hold 60% share, followed by portable (28%) and handheld (12%) solutions. Portable systems are the fastest-growing segment, offering affordability and mobility. By application, obstetrics & gynecology (25%), cardiology (20%), oncology (15%), musculoskeletal (12%), and abdominal imaging (10%) dominate use cases. Hospitals and diagnostic centers collectively account for 85% of total installations. 3D/4D and Doppler imaging systems are projected to lead the premium equipment segment, while AI-assisted reporting tools will enhance utilization across outpatient clinics and telemedicine providers.

Dubai (45%), Abu Dhabi (35%), and Sharjah (10%) drive the majority of the market, with the remainder distributed across Ajman, Ras Al Khaimah, and Fujairah. Dubai Healthcare City and Abu Dhabi’s SEHA network serve as technology adoption hubs, piloting AI diagnostic imaging projects with vendors like GE Healthcare and Philips. Northern Emirates are experiencing increased portable ultrasound penetration for primary and maternal health programs. The UAE’s position as a regional medical tourism hub further supports imaging volume growth, especially in preventive and cardiac diagnostics.
Key market players include GE Healthcare, Philips, Siemens Healthineers, Canon Medical, Samsung Medison, Mindray, and Fujifilm Sonosite. GE and Philips dominate premium cart-based ultrasound segments, while Mindray and Samsung Medison lead portable deployments. Siemens Healthineers and Canon Medical are investing in AI-assisted imaging and cloud-based archiving solutions tailored for UAE smart hospitals. Local firms, such as Gulf Drug LLC and Mediserv, are partnering with global OEMs to enhance distribution and service capacity. Emerging startups specializing in AI-driven diagnostic analytics, like InstaScan AI, are adding value through cloud-enabled interpretation tools, aligning with the UAE’s vision for a fully digital and preventive healthcare ecosystem.

This report quantifies the clinical nutrition market across the US and UK (2025–2030), covering enteral, parenteral, and oral nutritional supplements (ONS). Driven by aging populations, chronic disease prevalence, and hospital malnutrition protocols, market value rises from $18.5B (2025) → $30.2B (2030) at a CAGR of 10.2%. Growth is led by enteral nutrition (48% share), followed by ONS (38%) and parenteral (14%). Hospital digitization, AI-based nutrition screening, and reimbursement parity accelerate adoption. ROI averages 16–22% for integrated hospital nutrition programs.